Predalone

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Predalone

Quick Facts

Property Description
Active ingredient Prednisolone Acetate
Form Suspension, Tablet, Cream
Pharmacological class Glucocorticoid (Adrenal Corticosteroid)
General purpose Anti-inflammatory and Immunosuppressive
Origin Synthetic

What is Prednisolone Acetate and What Class of Medicine is it?

Prednisolone Acetate is a high-potency, synthetic glucocorticoid clinically recognized for its powerful anti-inflammatory and immunosuppressive effects. It belongs to the broader class of adrenal corticosteroids, which are agents designed to mimic the action of hormones naturally produced by the adrenal glands. These compounds are utilized widely across medicine for their capacity to modulate immune system activity. This means the medicine is chemically designed to help the body manage inflammation and allergic responses.

The active ingredient is chemically the C-21 acetate ester of Prednisolone, a structure manufactured through chemical synthesis. This ester form is often utilized in specialized suspension formulations because the acetate group can influence particle stability and the rate of drug release, which is a differentiating factor from the base compound. It is typically deployed as a single-ingredient product (monotherapy), with its therapeutic effects stemming solely from its potent steroidal classification.

Origin, Composition, and Pharmaceutical Forms of Prednisolone Acetate

Prednisolone Acetate is prepared in several essential dosage form(s), reflecting the need for both localized and systemic treatment. The medicine is commonly formulated as a sterile, topical ophthalmic suspension (eye drops), an injectable suspension for specific targeted delivery, a solid oral tablet, or a topical cream.

Its core composition involves the active ingredient combined with a suitable base/vehicle tailored for the administration route. For instance, the specialized microfine particle size required for the ophthalmic suspension is engineered specifically to allow effective ocular administration. The versatility of Prednisolone Acetate, available in forms suited for ocular, oral, and topical routes, is a key characteristic setting it apart from drugs limited to a single mode of application.

General Purpose: How This Glucocorticoid Helps Relieve Symptoms

The general therapeutic purpose of this medication is to help control inflammation and alleviate symptoms resulting from excessive immune or allergic responses. The medication serves an essential role in mitigating the effects of immune reactions and tissue inflammation. This powerful, multi-level action is typically utilized when a patient requires rapid suppression of redness, swelling, or pain. As a glucocorticoid, it acts at multiple points within the body’s defensive cascades, making it highly effective at moderating tissue reactions.

Regulatory References

  1. WHO Essential Medicines List

What side effects are possible with Predalone?

Possible Side Effects and Safety Information

The safety profile of this medicine, a glucocorticoid, is defined by its anti-inflammatory and immunosuppressive actions. The potential for side effects is related to the dose, duration of exposure, and administration route, with systemic use (e.g., oral tablets) typically associated with a wider range of reactions than localized ophthalmic use.

System-Organ-Class Safety Profile

Official regulatory documents classify adverse reactions across several System-Organ Classes (SOCs). Common effects of systemic use include fluid retention, weight gain due to increased appetite, hypertension (elevated blood pressure), and mood changes.

System-Organ Class Key Adverse Reactions Documented
Endocrine/Metabolic HPA axis suppression, Cushingoid state, altered glucose tolerance, menstrual irregularities
Musculoskeletal Osteoporosis, muscle weakness, aseptic necrosis, pathological bone fracture
Gastrointestinal Peptic ulceration (risk of hemorrhage/perforation), pancreatitis

Ophthalmic and Duration-Related Safety

For the ophthalmic suspension (eye drops), the most frequently reported reaction is the elevation of intraocular pressure (IOP), which, with prolonged use, carries the documented risk of developing glaucoma and posterior subcapsular cataracts. Long-term use or abrupt withdrawal of systemic therapy can lead to acute adrenal insufficiency.

Special Population and Safety Constraints

Regulatory safety notes indicate specific considerations for vulnerable groups. Systemic use may cause growth suppression in children and pose risks to the nursing infant. Furthermore, the ophthalmic form is contraindicated in the presence of certain active viral or fungal ocular infections.

Overdose and Emergency Response

Overdose and When to Seek Help

Prednisolone Acetate overdose is primarily documented in regulatory labeling as a consequence of chronic, prolonged, high-dose exposure rather than a single massive acute ingestion. A single acute overdose is generally not associated with specific acute toxic symptoms. The critical manifestations relate to the clinical signs of hypercortisolism (Cushingoid syndrome) and severe systemic effects, which necessitate regulatory guidance on seeking help.

The most serious outcomes affect the fluid and electrolyte balance, potentially resulting in severe Hypokalemic alkalosis and significant Hypertension that can escalate to a hypertensive crisis. The endocrine system risk involves adrenal suppression (HPA axis suppression), especially upon abrupt withdrawal after chronic exposure.

Immediate medical attention is required for any suspected massive acute overdose. Urgent medical consultation or contact with emergency services is mandated if severe, persistent signs of chronic excess—such as marked Cushingoid features, severe fluid retention, or high blood pressure—are observed during treatment.

The official management strategy is defined as strictly symptomatic and supportive. Regulatory information confirms that no specific antidote is known for this overdose. Supportive measures include correcting electrolyte imbalances and managing severe hypertension. Hospital monitoring is often required to assess the severity of metabolic disturbances and check for HPA axis suppression.

Therapeutic Uses of Predalone

What Predalone Treats: Main Uses and Benefits

The medication is commonly used across conditions presenting with acute episodes to offer symptomatic relief that helps patients cope more steadily. The medication is applied across domains where additional symptomatic support is needed in situations involving certain distressing symptoms. It is considered relevant in contexts marked by increased discomfort or tension in conditions involving episodic or fluctuating manifestations. It is generally used across domains where short-term symptomatic assistance is appropriate to help patients cope more steadily with difficult episodes.

It is generally used to address symptoms related to inflammatory or irritative states in the eye, for example, in conditions presenting with localized discomfort, or used in situations involving certain distressing symptoms during acute flare-ups of conditions such as rheumatoid arthritis, severe allergic reactions, and acute respiratory distress.

“The medicine helps improve day-to-day comfort during symptomatic periods and supports the patient during difficult episodes by easing distress.”

Quick Fact: Relief for Symptoms related to physical discomfort

The medication is relevant for easing symptom clusters that may become intense or disruptive, often used during phases when symptoms become temporarily overwhelming. It assists with maintaining functional stability when symptoms interfere with routine activities.

Regulatory References

  1. NIH MedlinePlus overview of Prednisolone uses

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use Predalone — Official Regulatory Information

Category Official Regulatory Statement
Populations for whom use is allowed (as stated in label) Adults and Geriatric Patients for both ophthalmic and systemic use, with no overall difference in safety observed in older adults.
Populations for whom use is contraindicated Individuals with Known Hypersensitivity to the drug or components, or Systemic Fungal Infections (for oral/systemic use).
Ophthalmic formulations are contraindicated in Acute Untreated Purulent Ocular Infections and most Viral Diseases of the Cornea (e.g., Herpes Simplex Keratitis), as well as in Mycobacterial or Fungal Diseases of Ocular Structures.
Age-related eligibility rules Pediatric Use (Ophthalmic): Safety and effectiveness have not been established for all ophthalmic products in children.
Condition-specific eligibility rules Hepatic Impairment: Systemic use is contraindicated in severe hepatic impairment (e.g., Child-Pugh Class C) for specific combination therapies. Renal Impairment requires caution due to limited clinical experience.
Pregnancy and lactation eligibility status Pregnancy: Use is conditional (e.g., US FDA Category C) and permitted only if the potential benefit justifies the potential risk to the fetus. Lactation: Use requires a decision to discontinue nursing or the drug due to the potential for infant growth suppression.

Eligibility Classifications (High-Level)

Category Official Regulatory Statement
Eligibility severity classification Contraindicated (Absolute prohibition); Use with Caution/Restricted (Conditional use requiring monitoring); Use Established (Standard use in adults).
Eligibility-context constraints Eligibility is formulation-dependent, with specific infection-based contraindications for the ophthalmic product not applicable to the oral/systemic product.

Connection to the Overall Eligibility Profile

Regulatory documents define eligibility by establishing clear and absolute barriers (contraindications) against use in the presence of specific infectious diseases, such as viral keratitis or systemic fungal infections, and known hypersensitivity. Furthermore, eligibility is restricted for certain populations, including pregnant or breastfeeding women, and those with pre-existing conditions like glaucoma or organ impairment, by mandating that use proceeds only under specific, documented cautionary conditions and monitoring.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile for Predalone (Prednisolone Acetate) is based on its classification as a glucocorticoid, with documented interactions falling into pharmacokinetic and pharmacodynamic categories as defined in regulatory labeling. This profile strictly details how co-administration with other substances is officially described by government health authorities.

Official Interaction Classifications

  • Contraindicated Combination: Co-administration with live or live attenuated vaccines is formally contraindicated when Predalone is administered at immunosuppressive doses.
  • Metabolism-Modifying Interactions: Substances that interact with the CYP 3A4 enzyme system alter Predalone exposure. CYP 3A4 Inducers (e.g., Rifampin, Phenytoin) may enhance the corticosteroid’s clearance, while CYP 3A4 Inhibitors (e.g., Ketoconazole, Erythromycin) may lead to increased plasma concentrations.
  • Reinforcing Pharmacodynamic Effects: Combining Predalone with certain medicines is documented to increase specific risks. For instance, co-administration with NSAIDs is associated with an increased risk of gastrointestinal side effects. The co-administration of Fluoroquinolones is formally noted as increasing the risk of tendon rupture. Agents that deplete potassium (e.g., Diuretics) increase the risk of hypokalemia.
  • Exposure-Altering Substances: Estrogens (including oral contraceptives) may decrease the hepatic metabolism of the corticosteroid, thereby increasing its effect.
  • Timing-Based Constraint: Regulatory labeling notes that Anticholinesterase Agents should be withdrawn at least 24 hours before initiating corticosteroid therapy, if feasible, in myasthenia gravis patients.
  • Population-Specific Notes: The metabolic clearance of the corticosteroid is officially documented as decreased in patients with hypothyroidism, and an enhanced effect is noted in patients with cirrhosis.

Mechanism of Action

Predalone is a synthetic glucocorticoid receptor (GR) agonist. As a lipophilic molecule, it readily traverses the cell membrane and binds to the cytosolic GR. This binding causes the receptor complex to dissociate from chaperone proteins, enabling its translocation into the nucleus.

Within the nucleus, the activated Predalone-GR complex modifies gene transcription via two primary mechanisms: transactivation and transrepression. Transactivation involves binding to positive glucocorticoid response elements (GREs), stimulating the expression of anti-inflammatory genes, such as those encoding annexin-A1 (lipocortin-1). Transrepression involves direct or indirect antagonism of pro-inflammatory transcription factors, including NF-kappaB and AP-1, thereby suppressing the transcription of genes for pro-inflammatory cytokines like IL-2, IL-6, and TNF-alpha.

These intracellular events result in downstream effects that modulate systemic physiology. The inhibition of phospholipase A2 activity via annexin-A1 expression decreases the production of eicosanoids, including prostaglandins and leukotrienes. Concurrently, the modulation of immune cell gene expression alters leukocyte kinetics, reducing circulating lymphocyte, monocyte, and eosinophil counts through increased apoptosis and redistribution, while increasing the peripheral neutrophil count. System-level consequences include the suppression of the hypothalamic-pituitary-adrenal (HPA) axis via negative feedback.

Dosage and Administration Information

How to Use Predalone: Official Administration Guidelines

Predalone is administered orally as directed by a healthcare provider. The official instructions for its use emphasize that the dosage is highly individualized and based on the specific condition and the patient's response to therapy. Therefore, it must be taken exactly as prescribed; you must never take more, less, or for a different duration than ordered.

Administration Details

Procedure Official Regulatory Instruction
Timing & Food Oral forms (tablet, solution, etc.) must be taken with food or milk to reduce potential stomach irritation. Doses are often prescribed once daily, frequently in the morning, to align with the body’s natural steroid production cycle.
Dosing Schedule Dosing is variable, typically starting higher and then gradually reduced to the lowest effective maintenance dose. The prescription may require the medicine to be taken daily or on alternate days.
Preparation Liquid forms must be measured using a calibrated measuring device (not a household spoon) for accuracy. Orally disintegrating tablets should be placed on the tongue, allowed to dissolve, and swallowed with saliva; they should not be chewed or broken.
Missed Dose If a dose is missed, it should be taken as soon as it is remembered, unless it is near the time for the next scheduled dose. In that case, the missed dose should be skipped; do not take two doses at once to catch up.

Discontinuation Requirement

Do not stop taking Predalone abruptly. The official instructions mandate that the drug be withdrawn gradually if it has been taken long-term or at high doses. Abrupt cessation can cause a severe withdrawal reaction. Your physician will provide a specific, structured dose-tapering schedule that must be followed precisely.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Predalone


Evidence for Use in Post-Surgical Ocular Inflammation

Prednisolone Acetate was observed in research exploring how symptoms change over time following common eye procedures, such as cataract surgery. These investigations were often conducted as short-term, randomized controlled trials (RCTs). Researchers primarily monitored outcomes linked to inflammatory or irritative states within the eye, including clinical signs like the number of inflammatory cells observed inside the eye's anterior chamber, and patient-reported outcomes describing perceived discomfort. Studies monitored data showing patterns related to how these signs of internal inflammation evolved in the studied groups over defined time intervals.

Evidence for Use in Anterior Uveitis (Internal Eye Inflammation)

Research has also explored the use of Prednisolone Acetate in conditions involving periods of heightened symptoms, such as non-infectious anterior uveitis. Studies focusing on episodes where symptoms become more noticeable have included comparative trials. Researchers primarily monitored changes in the inflammatory cell counts in the eye. Studies reported how symptoms evolved in the observed populations and described the frequency with which participants achieved a specific study endpoint related to the clearance of the inflammatory cells measured. The use of the formulation in patients with posterior or panuveitis was not evaluated in these specific uveitis studies.


Areas Where Research Remains Uncertain

While evidence contributes to the broader evidence landscape, certainty remains low regarding the long-term effects of using the eye drops, as the follow-up durations were limited in most trials. Comparative evidence is lacking in some scenarios, making it difficult to explore comparisons between this specific formulation and certain other available treatments. Subgroup findings are uncertain for many unique or high-risk patient characteristics. Research examining specific findings for pregnant patients or patients with complex, rare comorbidities in the context of ocular inflammation is still emerging.

Key Studies & References

  1. Prednisolone: Drug Information
  2. WHO Model List of Essential Medicines

Frequently Asked Questions (FAQ)

Common questions about Predalone (FAQ)

Q: Is it normal to feel a sudden burst of energy or mood change shortly after taking Predalone?

Official information indicates that psychological and mood changes are documented side effects of this type of medicine. These reactions can include feelings of euphoria, which is a burst of elevated mood, as well as emotional instability and difficulty sleeping (insomnia). Regulatory warnings indicate that patients and caregivers should be informed about the possibility of these psychiatric adverse reactions.


Q: What kind of long-term side effects are people most concerned about when taking Predalone for an ongoing condition?

Regulatory documents highlight several potential concerns with long-term use. These include the risk of developing a Cushingoid state, which involves specific changes to the body’s appearance, and suppression of the HPA axis (the body’s natural cortisol production system). Other documented risks are the loss of bone density (osteoporosis), muscle weakness, and, with the eye-drop formulation, the development of glaucoma and cataracts.


Q: Can Predalone cause weight gain, and if so, what is the mechanism behind it?

Weight gain is listed as a common adverse reaction in official product information. This effect is often related to two documented factors: an increased appetite and the body retaining extra fluid and salt (sodium retention). Prolonged use may also contribute to the development of a Cushingoid state, which involves specific changes in fat distribution.


Q: Is there a best time of day to take Predalone to minimize side effects like insomnia or stomach upset?

To align with the body’s natural cycle of steroid production, doses are often prescribed once daily in the morning. This approach, aligning with the body’s natural cycle, is intended to help reduce certain side effects, such as trouble sleeping (insomnia). Furthermore, official guidelines state the oral forms should be taken with food or milk to help reduce potential stomach irritation.


Q: What are the signs of adrenal gland suppression or adrenal insufficiency that I should be aware of?

Official documentation describes signs of secondary adrenocortical unresponsiveness, which is another term for adrenal insufficiency. These signs can include unusual weakness or fatigue, dizziness or fainting, and stomach issues like nausea or vomiting. Loss of appetite and unexplained weight loss are also associated with this condition, particularly during times of physical stress.


Q: Can Predalone affect blood sugar levels, even in people who don't have diabetes?

Yes, official regulatory information states that this medicine can cause decreased carbohydrate tolerance. This means it has the potential to raise blood sugar levels, which can make pre-existing diabetes worse or lead to the manifestation of latent (previously undiagnosed) diabetes mellitus in some individuals.


Q: Are there any specific dietary changes recommended while taking Predalone, such as low-sodium or high-potassium?

The medicine is documented to affect the body's fluid and electrolyte balance, specifically causing sodium retention (which leads to fluid retention) and loss of potassium (hypokalemia). While the official label does not mandate a specific diet, these documented effects indicate that a healthcare provider may determine that monitoring or adjusting the patient's intake of sodium and potassium is necessary.


Q: What is the difference between the oral tablet/liquid forms and the injectable or topical forms of Predalone?

The drug is formulated in various ways, including oral tablets, injectable suspensions, and ophthalmic (eye drop) suspensions. The key difference is the route of administration, which determines the area of effect. The oral and injectable forms lead to systemic (body-wide) effects, while the ophthalmic form provides localized treatment. Systemic use is generally associated with a wider range of potential side effects than localized use.


Q: Is Predalone used to treat allergic reactions, and how effective is it in those situations?

Yes, the medicine is officially indicated for the management of severe or debilitating allergic conditions that have not responded well to standard treatments, such as certain cases of bronchial asthma or severe contact dermatitis. Its use in these situations is due to its powerful anti-inflammatory and immunosuppressive properties that help control the body’s excessive immune response.


Q: What are some psychological or mood side effects commonly reported with Predalone use?

Official adverse reaction reports document a range of psychological effects. These can include mood swings, feelings of euphoria, difficulty sleeping (insomnia), and changes in personality. More severe psychiatric reactions, such as severe depression or psychosis, are also possible, and patients with pre-existing psychiatric conditions may experience an aggravation of their symptoms.


Q: How long does Predalone stay in the body after the last dose is taken?

Pharmacokinetic data from regulatory sources indicate that the active form of the drug, prednisolone, has an average half-life in the bloodstream of approximately 18 to 36 hours. The 18 to 36 hour half-life indicates the time it takes for half of the dose to be cleared from the body.


Q: Is it possible for Predalone to reactivate a past infection, like chickenpox or herpes?

Official warnings state that corticosteroids can increase the risk of an existing or past latent (inactive) infection becoming active again, known as reactivation. This includes infections caused by viruses, fungi, or protozoa. This is a consequence of the medicine’s primary action as an immunosuppressant, which reduces the body’s ability to keep those pathogens in check.


Q: Does Predalone affect energy metabolism or cause muscle weakness over time?

Yes, regulatory information documents that glucocorticoids are known to cause profound changes in the body’s metabolism, including a negative nitrogen balance due to the breakdown of protein (catabolism). This catabolic effect can lead to side effects like muscle weakness, loss of muscle mass, and a condition known as steroid myopathy.


Q: Can taking Predalone affect the results of certain medical lab tests?

Official product information notes that the medicine may interfere with the results of certain medical tests. Specifically, it can suppress the body’s reaction to skin tests used to diagnose conditions like allergies or tuberculosis. It also influences laboratory parameters like blood pressure, blood glucose levels, and the balance of electrolytes such as sodium and potassium.


Q: What is the role of Predalone in treating severe flare-ups of chronic conditions?

The drug is indicated for use as a short-term, supplemental treatment to help manage an acute episode or severe flare-up of certain chronic conditions. This is often done to help 'tide the patient over' the difficult period of exacerbation in conditions such as rheumatoid arthritis, ulcerative colitis, or severe asthma or COPD exacerbations.


Q: Can Predalone cause a feeling of being restless or agitated, and how is that managed?

Yes, official documentation includes both agitation and restlessness among the potential adverse reactions. Regulatory documents state that any patient who experiences concerning psychological symptoms while taking the medication should inform their healthcare provider.


Q: Is there a maximum safe duration for taking Predalone to reduce the risk of serious side effects?

The official documentation does not define a single maximum safe duration for all patients. Instead, it advises that the potential for side effects is directly related to the dose and the length of time the medication is used. Official prescribing information advises that the medicine be used at the lowest effective dose for the shortest possible duration to help manage the risk of adverse reactions.


Q: Does Predalone have any effect on blood clotting or wound healing?

Yes, official adverse event reports document that this medicine can have effects on both processes. Impaired or delayed wound healing is a documented side effect. Furthermore, the formation of blood clots (thromboembolism) is also listed as a potential cardiovascular adverse event associated with the use of this type of medication.

How should Predalone be stored and disposed of?

How to Store and Dispose of Prednisolone Acetate

Prednisolone Acetate must be stored according to official regulatory specifications to maintain its effectiveness. Tablets and oral solutions are generally required to be stored at Controlled Room Temperature (20 C to 25 C). The oral solution must not be refrigerated, and the ophthalmic suspension must not be frozen.

Storage Conditions

Condition Requirement
Temperature 20 C to 25 C for oral forms.
Protection Keep in a tight, light-resistant container.
Handling Store away from moisture; ophthalmic suspension must be shaken well before use.
Safety Keep out of the sight and reach of children.

Disposal

Disposal of unused or expired product must follow official governmental guidance. This often involves using a drug take-back program. If a program is unavailable, the product should be mixed with an undesirable substance and sealed in a container for disposal in the household trash, avoiding disposal into wastewater.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Predalone found in:

A-Z Index: